sidichen Profile Banner
Sidi Chen Profile
Sidi Chen

@sidichen

Followers
1K
Following
289
Media
3
Statuses
52

Gene editing. Technology. Cancer. Immunology. Cell and gene therapy. Antibody. mRNA vaccine. @ Yale Genetics & Systems Biology. ## CRISPR in vivo ##

New Haven, CT
Joined December 2010
Don't wanna be here? Send us removal request.
@sidichen
Sidi Chen
1 month
Proud to present our work at #KCRS25 on CAR-T screens, cell therapy and kidney cancer from @YaleMed @YaleGenetics @YaleWestCampus @YaleCancer Honored to be in session with Drs. Chuck Drake at JnJ, Nadal Rios at Hutch & Patrick Ott at Farber, hosted by David Braun &Hans Hammers.
0
2
16
@grok
Grok
21 days
The most fun image & video creation tool in the world is here. Try it for free in the Grok App.
0
151
2K
@sidichen
Sidi Chen
1 month
RT @kidneycan: #KCRS25 Session 6 highlighted how researchers are pushing the boundaries of what immunotherapy can do for kidney cancer pati….
0
1
0
@sidichen
Sidi Chen
2 months
RT @CancerResearch: 🎉 CRI is proud to announce the 2025 CLIP and Technology Impact Award projects, a new class of high‑potential studies an….
Tweet card summary image
cancerresearch.org
Discover CRI’s 2025 CLIP and Technology Impact Award projects—funding bold cancer immunotherapy research and new tools to advance treatments.
0
3
0
@sidichen
Sidi Chen
3 months
Organizing an AI symposium on 6/20 with SAPA-CT at Yale. Please check it out and all are welcome to register/attend! @YaleWestCampus
Tweet media one
0
1
10
@sidichen
Sidi Chen
4 months
Excited to present our new work on multiplex immune gene therapies for cancer @ASGCT 2025 @NOLA @YaleMed @YaleCancer @YaleGenetics @YaleWestCampus
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
3
15
@sidichen
Sidi Chen
4 months
RT @YaleCancer: .@sidichen co-chairs a symposium highlighting the transformative field of adoptive cell therapies for #cancer treatment #AA….
0
4
0
@sidichen
Sidi Chen
5 months
Our lab generated 4 new lines of Cas12a transgenic mice and demonstrated utility in immune engineering, tumor modeling, and genetic disease treatment. Around to share w the field & community! @YaleMed @YaleWest @YaleGenetics @YaleData Also @LabWinslow
Tweet card summary image
nature.com
Nature Biomedical Engineering - Knock-in mice conditionally or constitutively expressing Cas12 variants enable a wide range of ex vivo and in vivo applications requiring multiplexed genome...
1
18
84
@sidichen
Sidi Chen
8 months
Our new “MUCIG” therapy @FF Zhang ⁦@ScienceChow@GW ⁩ ⁦@YaleCancer⁩ ⁦@YaleGenetics⁩ ⁦@YaleWestCampus⁩ .Multiplexed inhibition of immunosuppressive genes with Cas13d for combinatorial cancer immunotherapy | Nature Biotechnology
1
2
17
@sidichen
Sidi Chen
8 months
Our team’s new work “MUCIG” cancer therapy - Multi-target approach counters tumor growth in several cancers | Yale News @Feifei Zhang ⁦@ScienceChow@Guangchuan Wang ⁦@Yale⁩ ⁦@YaleCancer⁩ ⁦@YaleGenetics⁩ ⁦@YaleWestCampus
Tweet card summary image
news.yale.edu
Yale scientists have developed a treatment approach that simultaneously targets multiple immune-suppressing genes and inhibits growth in four types of cancer.
1
1
12
@sidichen
Sidi Chen
1 year
Honored to serve on the panel of #AI for drug discovery in biomedicine at #AIME 2024 Utah. Very stimulating discussions on future of medicine, challenges etc, with experts and audience. @YaleData @yaledatascience @YaleGenetics @YaleCancer @Yale_Ventures
Tweet media one
0
2
13
@sidichen
Sidi Chen
1 year
Our first in vivo primary NK screen that discovered new NK cellular checkpoints. Kudos for team for their 5 years of work. @YaleGenetics @YaleMed @YaleWestCampus @YaleCancer @YaleData.
Tweet card summary image
nature.com
Nature Biotechnology - The antitumor efficacy of chimeric antigen receptor natural killer cells is enhanced by genetic engineering.
3
25
130
@sidichen
Sidi Chen
1 year
RT @AIHealthMIT: “Building a community and paying attention to that community is the essence of getting things done.” .Today #JameelClinic….
0
2
0
@sidichen
Sidi Chen
1 year
Our new high fidelity enhanced AsCas12a/Cpf1 transgenic mice after five years of work. Generated by Matt Dong and colleagues here in lab at @YaleGenetics @YaleCancer @YaleMed @YaleWestCampus Anyone who want to try them out feel free to please contact us.
Tweet card summary image
biorxiv.org
The advancement of CRISPR gene editing technology, especially the development of Cas9 knock-in mice, has significantly boosted the functional discovery of various genetics factors in diverse fields...
0
6
30
@sidichen
Sidi Chen
1 year
Got the cover for this one as well at Nature Biomedical Engineering :).
0
0
0
@sidichen
Sidi Chen
1 year
Congrats for Ariel Xiaoyu Zhou my postdoc in @YaleCancer @YaleGenetics @YaleMed @YaleWestCampus @YaleData getting an NIH/NCI K99/R00 award starting this month to study T cells and engineer next generation CAR-T cell therapy for cancer!.
0
1
16
@sidichen
Sidi Chen
2 years
RT @YaleGenetics: 🤩🤩 Beautiful cover art @NatureBiotech depicting new paper led by Xiaoyun Dai @sidichen lab 👇🏽👇🏿👇.
0
2
0
@sidichen
Sidi Chen
2 years
RT @FrontGenEditing: We are thrilled to announce the official launch of Genome Editing in Cancer and Immunology, a specialty section journa….
0
2
0
@sidichen
Sidi Chen
2 years
Our work at Nature Immunology on a new way of cell therapy engineering. Proud of 1st author Ariel & team. Special Tx to Dr. Levchenko. @Yale @YaleGenetics @YaleCancer @YaleWestCampus @YaleData @YaleMed
3
19
81